đ° Full Story
On April 2, 2026 U.S. agencies moved to study and monitor microplastics and pharmaceuticals in public drinking water for the first time.
The Environmental Protection Agency placed both contaminant groups on a draft Sixth Contaminant Candidate List (CCL 6), which also flags PFAS and disinfection byproducts among 75 chemicals and nine microbes.
Listing on the CCL does not immediately impose enforceable limits but prioritizes research, monitoring and funding that can lead to future regulation under the Safe Drinking Water Act; a 60-day public comment period is open and the list is expected to be finalized by midâNovember 2026.
Health and Human Services Secretary Robert F. Kennedy Jr. announced a related $144 million STOMP (Systemic Targeting of MicroPlastics) program to develop standardized detection tools, study health effects and explore removal strategies.
The EPA also released human health benchmarks for 374 pharmaceuticals.
Agency leaders framed the measures as a response to public concern, while scientists, industry groups and advocates cautioned that methods and health evidence remain limited and that listing only starts a lengthy regulatory process.





đŹ Commentary